- Home
- SLBT vs IRMD Comparison
SLBT vs IRMD Comparison
Compare SLBT & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLBT | IRMD |
|---|---|---|
| Founded | N/A | 1992 |
| Country | Taiwan | United States |
| Employees | 20 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | SLBT | IRMD |
|---|---|---|
| Price | $2.65 | $90.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $116.00 |
| AVG Volume (30 Days) | ★ 145.3K | 97.8K |
| Earning Date | N/A | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 0.45 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | N/A | $12.38 |
| Revenue Next Year | N/A | $11.31 |
| P/E Ratio | ★ N/A | $212.02 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $2.54 | $67.29 |
| 52 Week High | $6.25 | $107.90 |
Technical Indicators
Market Signals| Indicator | SLBT | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 50.88 |
| Support Level | N/A | $90.96 |
| Resistance Level | $4.91 | $97.63 |
| Average True Range (ATR) | 0.37 | 3.14 |
| MACD | -0.14 | -0.23 |
| Stochastic Oscillator | 7.91 | 58.48 |
Price Performance
Historical ComparisonAbout SLBT SL Science Holding Limited Ordinary Shares
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.